Surgical Navigation System for Osteoarthritis
Trial Summary
What is the purpose of this trial?
The purpose of this research is to gather clinical and radiographic (X-ray) information about EMPHASYS™ acetabular shell (also called a hip 'cup') placement in total hip replacement surgery using a non-invasive surgical navigation system called VELYS™ hip navigation system with CUPTIMIZE™ Hip-Spine Analysis software. Data collected in this study will be compared with data collected from implantations using different cup positioning instrumentation and techniques to assess performance.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, if you are taking prescription medications for a muscular disorder that limits mobility, you may not be eligible to participate.
What data supports the effectiveness of the treatment EMPHASYS Cup with VHN for osteoarthritis?
The research shows that using navigation systems, like the electromagnetic navigation (EMN) system, improves the precision and accuracy of placing components in hip surgeries compared to doing it by hand. This suggests that similar navigation systems could help ensure precise placement of the EMPHASYS Cup, potentially improving outcomes for osteoarthritis treatment.12345
Is the surgical navigation system for osteoarthritis safe for humans?
How is the EMPHASYS Cup with VHN treatment for osteoarthritis different from other treatments?
The EMPHASYS Cup with VHN treatment is unique because it uses a surgical navigation system that does not rely on CT scans, making it less invasive and potentially more accurate in placing hip components during surgery. This system helps improve the positioning of the components, which can reduce the risk of dislocation and improve the longevity of the hip replacement.39101112
Eligibility Criteria
This trial is for individuals with various hip conditions such as avascular necrosis, arthritis, osteoarthritis, ankylosis, developmental dysplasia of the hip, congenital hip dislocation, rheumatoid arthritis, and hip dysplasia who require a total hip replacement.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Surgical Procedure
Participants undergo total hip replacement surgery using the VELYS™ hip navigation system
Immediate Post-Operative Assessment
Assessment of leg length discrepancy and operating room times immediately after surgery
Treatment Follow-up
Participants are monitored for inclination and anteversion success, and functional outcomes using various scores
Extended Follow-up
Further monitoring of functional and health status using Harris Hip Score, EQ-5D-5L, and radiographic outcomes
Long-term Follow-up
Monitoring of complication rates over a 90-day period
Treatment Details
Interventions
- EMPHASYS Cup with VHN
Find a Clinic Near You
Who Is Running the Clinical Trial?
DePuy Orthopaedics
Lead Sponsor
Massimo Calafiore
DePuy Orthopaedics
Chief Executive Officer since 2023
MBA from Harvard Business School
Dr. Michael Stein
DePuy Orthopaedics
Chief Medical Officer since 2023
MD from University of Michigan